Finnzymes Instruments licensed key patents for the worldwide manufacture, sale and use of thermal cyclers from Applera in November 2006
CEO Pekka Mattila stated: "It has always been Finnzymes's continuing strategy to license technologies and patents that will help develop a more complete product offering to the scientific community.
"In this case, we feel that offering both licensed reagents and PCR instruments will make it easier for our customers to purchase our integrated solution for high performance PCR."
